A survey of etiologic hypotheses among testicular cancer researchers

Andrology

Volumn 3, Issue 1, 2015, Pages 19-26

  Stang, A ^a,b   Trabert, B ^c   Rusner, C ^d   Poole, C ^e   Almstrup, K ^f   Rajpert De Meyts, E ^f   Mcglynn, K A ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b BOSTON UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e University of North Carolina at Chapel Hill   (United States)

^f University of Copenhagen   (Denmark)

Author keywords

Etiology; Survey; Testicular neoplasms; Testis; Testis cancer

Indexed keywords

ARTICLE; BASIC RESEARCH; CANCER RESEARCH; CLINICAL MEDICINE; HUMAN; LOW DRUG DOSE; MALE; PHYSICIAN; PREGNANCY; PRIORITY JOURNAL; SUGAR INTAKE; TESTIS CANCER; CONSENSUS; FEMALE; PERSONNEL; PRENATAL EXPOSURE; PSYCHOLOGY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; TESTICULAR NEOPLASMS;

CONSENSUS; FEMALE; HUMANS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RESEARCH PERSONNEL; RISK ASSESSMENT; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TESTICULAR NEOPLASMS;

EID: 84923260352     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/andr.306     Document Type: Article

References (34)

1. Banks K, Tuazon E, Berhane K, Koh CJ, De Filippo RE, Chang A, Kim SS, Daneshmand S, Davis-Dao C, Lewinger JP, Bernstein L & Cortessis VK (2013) Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics. Front Endocrinol 3, 182.
2. Beard CJ, Travis LB, Chen MH, Arvold ND, Nguyen PL, Martin NE, Kuban DA, Ng AK & Hoffman KE (2013) Outcomes in stage I testicular seminoma: a population-based study of 9193 patients. Cancer 119, 2771-2777.
3. Brabrand S, Fossa SD, Cvancarova M, Axcrona U & Lehne G. (2012) Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer. J Clin Oncol 30, 4004-4010.
4. Brody JP (2011) Age-specific incidence data indicate four mutations are required for human testicular cancers. PLoS ONE, 6, e25978.
5. Comish PB, Drumond AL, Kinnell HL, Anderson RA, Matin A Meistrich ML & Shetty G. (2014) Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice. PLoS ONE, 9, e93311.
6. Connell L & Keane MT. (2004) What plausibly affects plausibility? Concept coherence and distributional word coherence as factors influencing plausibility judgments. Mem Cognit 32, 185-197.
7. Cook MB, Trabert B & MyGlynn KA. (2011) Organochlorine compounds and testicular dysgenesis syndrome: human data. Int J Androl 34, e68-e84.
8. Dieckmann KP, Hartmann JT, Classen J, Lüdde R, Diederichs M & Pichlmeier U. (2008) Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis. Br J Cancer 99, 1517-1521.
9. Dossus L & Kaaks R. (2008) Nutrition, metabolic factors and cancer risk. Best Pract Res Clin Endocrinol Metab 22, 551-571.
10. Ginsburg J. (1997) Unanswered questions in carcinoma of the testis. Lancet 349, 1785-1786.
11. Giordano F, Carbone P, Nori F, Mantovani A, Taruscio D & Figa-Talamanca I. (2008) Maternal diet and the risk of hypospadias and cryptorchidism in the offspring. Paediatr Perinat Epidemiol 22, 249-260.
12. Godmann M, Lambrot R & Kimmins S. (2009) The dynamic epigenetic program in male germ cells: Its role in spermatogenesis, testis cancer, and its response to the environment. Microsc Res Tech 72, 603-619.
13. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B & Senn HJ. (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24, 2206-2223.
14. Hardell L, van Bavel B, Lindström G, Carlberg M, Dreifaldt AC, Wijkström H, Starkhammar H, Eriksson M, Hallquist A & Kolmert T (2003) Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ Health Perspect 111, 930-934.
15. Joensen UN, Jøgensen N, Meldgaard M, Frederiksen H, Andersson AM, Menné T, Johansen JD, Carlsen BC, Stender S, Szecsi PB, Skakkebaek NE, Rajpert-De Meyts E & Thyssen JP (2014) Associations of Filaggrin gene loss-of-function variants with urinary phthalate metabolites and testicular function in young Danish men. Environ Health Perspect 122, 345-350.
16. Kahnemann D. (2011) Thinking, Fast and Slow. Penguin Books Ltd, London.
17. Kristensen DM, Hass U, Lesné L, Lottrup G, Jacobsen PR, Desdoits-Lethimonier C, Boberg J, Petersen JH, Toppari J, Jensen TK, Brunak S, Skakkebaek NE, Nellemann C, Main KM, Jegou B & Leffers H. (2011) Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 26, 235-244.
18. van Leeuwen M, Efficace F, Fossa SD, Bolla M, De Giorgi U, de Wit R, Holzner B, van de Poll-Franse LV, van Poppel H, White J, Collette L, Osanto S & Aaronson NK. (2014) Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities. Eur J Cancer 50, 1957-1963.
19. Lip SZ, Murchison LE, Cullis PS, Govan L & Carachi R. (2013) A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Arch Dis Child 98, 20-26.
20. Liu M, Hales BF & Robaire B. (2014) Effects of four chemotherapeutic agents, bleomycin, etoposide, cisplatin, and cyclophosphamide, on DNA damage and telomeres in a mouse spermatogonial cell line. Biol Reprod 90, 72.
21. McGlynn KA & Cook MB. (2009) Etiologic factors in testicular germ-cell tumors. Future Oncol 5, 1389-1402.
22. McGlynn KA & Trabert B. (2012) Adolescent and adult risk factors for testicular cancer. Nat Rev Urol 9, 339-349.
23. Møller H, Prener A & Skakkebaek NE. (1996) Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control 7, 264-274.
24. Oosterhuis JW & Looijenga LH. (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5, 210-222.
25. Pierik FH, Burdorf A, Deddens JA, Juttmann RE & Weber RF. (2004) Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys. Environ Health Perspect 112, 1570-1576.
26. Rajpert-De Meyts E & Skakkebaek NE. (2011) Pathogenesis of testicular carcinoma in situ and germ cell cancer: still more questions than answers. Int J Androl 34, e2-e6.
27. Shetty G, Comish PB, Weng CC, Matin A & Meistrich ML (2012) Fetal radiation exposure induces testicular cancer in genetically susceptible mice. PLoS ONE, 7, e32064.
28. Shetty D, Bailey AG & Freeman SJ. (2014) Testicular microlithiasis an ultrasound dilemma: survey of opinions regarding significance and management amongst UK ultrasound practitioners. Br J Radiol 87, 20130603.
29. Taubes G (2012) Cancer research. Unraveling the obesity-cancer connection. Science, 335, 28, 30-28, 32.
30. Trabert B, Longnecker MP, Brock JW, Klebanoff MA & McGlynn KA. (2012) Maternal pregnancy levels of trans-nonachlor and oxychlordane and prevalence of cryptorchidism and hypospadias in boys. Environ Health Perspect 120, 478-482.
31. Trabert B, Chodick G, Shalev V, Sella T, Longnecker MP & McGlynn KA. (2014) Gestational diabetes and the risk of cryptorchidism and hypospadias. Epidemiology 25, 152-153.
32. Virtanen HE, Tapanainen AE, Kaleva MM, Suomi AM, Main KM, Skakkebaek NE & Toppari J. (2006) Mild gestational diabetes as a risk factor for congenital cryptorchidism. J Clin Endocrinol Metab 91, 4862-4865.
33. Virtanen HE, Sadov S & Toppari J. (2012) Prenatal exposure to smoking and male reproductive health. Curr Opin Endocrinol Diabetes Obes 19, 228-232.
34. Yousif L, Blettner M, Hammer GP & Zeeb H. (2010) Testicular cancer risk associated with occupational radiation exposure: a systematic literature review. J Radiol Prot 30, 389-406.